Global and United States Immune system drugs In-Depth Research Report 2017-2022

August 2017 | 125 pages | ID: GE1C25B05E0EN
US Market Insights (UMI)

Abstracts

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Immune system drugs industry.

Major Companies

• ABBVIE
• ACCORD HLTHCARE
• AKORN INC
• ALLERGAN
• AMNEAL PHARMS LLC
• ANTARES PHARMA INC
• APOTEX
• ASTELLAS
• BAXTER HLTHCARE
• BAYER HEALTHCARE PHARMS
• DAVA PHARMS INC
• DR REDDYS LABS LTD
• FRESENIUS KABI USA
• GLENMARK GENERICS
• HOSPIRA
• IVAX SUB TEVA PHARMS
• MAYNE PHARMA
• MYLAN
• NOVARTIS
• ROCHE PALO
• SANDOZ
• SANOFI AVENTIS US
• STRIDES PHARMA
• TEVA PHARMS
• VELOXIS PHARMS INC
• VIDARA THERAPEUTICS RESEARCH LTD
• VINTAGE PHARMS LLC
• WATSON LABS
• WEST-WARD PHARMS INT
• ZYDUS PHARMS USA

Key Regions

• North America
• United States
• California
• Texas
• New York
• Others
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Main types of products

Immune system drugs Market, by Immunosuppressive drugs

• Azathioprine
• Tripterygium Glycosides
• Cyclosporine
• Sandimmune
• Ciclosporin
• Cyclosporine
• Neoral
• Tacrolimus
• Rapamycin
• Mycophenolate
• Everolimus
• Diacerein
• Mizoribine
• Gusperimus
• Etanercept
• Muromonab-CD3
• Cyclophosphamide
• Fingolimod
• Leflunomide
• Imiquimod
• Chloroquinum
• Methotrexate

Immune system drugs Market, by Immunoregulants

• Inosine pranobex
• Melotonin
• Killer helper factor,KHF
• Thymopentin
• Interleukin
• γ-globulin
• Interferon
• Ubenimex
• Pidotimod
• Thymopentin

Immune system drugs Market, by Key Consumers

• Internal Medicine
• Department of surgery
• Infections Department
• Hospital

Contents

CHAPTER ONE GLOBAL IMMUNE SYSTEM DRUGS MARKET OVERVIEW

1.1 Global Immune system drugs Market Sales Volume Revenue and Price 2012-2017
1.2 Immune system drugs, by Immunosuppressive drugs 2012-2017
  1.2.1 Global Immune system drugs Sales Market Share by Immunosuppressive drugs 2012-2017
  1.2.2 Global Immune system drugs Revenue Market Share by Immunosuppressive drugs 2012-2017
  1.2.3 Global Immune system drugs Price by Immunosuppressive drugs 2012-2017
  1.2.4 Azathioprine
  1.2.5 Tripterygium Glycosides
  1.2.6 Cyclosporine
  1.2.7 Sandimmune
  1.2.8 Ciclosporin
Cyclosporine
Neoral
Tacrolimus
Rapamycin
Mycophenolate
Everolimus
Diacerein
Mizoribine
Gusperimus
Etanercept
Muromonab-CD3
Cyclophosphamide
Fingolimod
Leflunomide
Imiquimod
Chloroquinum
Methotrexate
1.3 Immune system drugs, by Immunoregulants 2012-2017
  1.3.1 Global Immune system drugs Sales Market Share by Immunoregulants 2012-2017
  1.3.2 Global Immune system drugs Revenue Market Share by Immunoregulants 2012-2017
  1.3.3 Global Immune system drugs Price by Immunoregulants 2012-2017
  1.3.4 Inosine pranobex
  1.3.5 Melotonin
  1.3.6 Killer helper factor,KHF
  1.3.7 Thymopentin
  1.3.8 Interleukin
γ-globulin
Interferon
Ubenimex
Pidotimod
Thymopentin

CHAPTER TWO UNITED STATES IMMUNE SYSTEM DRUGS MARKET OVERVIEW

2.1 United States Immune system drugs Market Sales Volume Revenue and Price 2012-2017
2.2 Immune system drugs, by Immunosuppressive drugs 2012-2017
  2.2.1 United States Immune system drugs Sales Market Share by Immunosuppressive drugs 2012-2017
  2.2.2 United States Immune system drugs Revenue Market Share by Immunosuppressive drugs 2012-2017
  2.2.3 United States Immune system drugs Price by Immunosuppressive drugs 2012-2017
  2.2.4 Azathioprine
  2.2.5 Tripterygium Glycosides
  2.2.6 Cyclosporine
  2.2.7 Sandimmune
  2.2.8 Ciclosporin
Cyclosporine
Neoral
Tacrolimus
Rapamycin
Mycophenolate
Everolimus
Diacerein
Mizoribine
Gusperimus
Etanercept
Muromonab-CD3
Cyclophosphamide
Fingolimod
Leflunomide
Imiquimod
Chloroquinum
Methotrexate
2.3 Immune system drugs, by Immunoregulants 2012-2017
  2.3.1 United States Immune system drugs Sales Market Share by Immunoregulants 2012-2017
  2.3.2 United States Immune system drugs Revenue Market Share by Immunoregulants 2012-2017
  2.3.3 United States Immune system drugs Price by Immunoregulants 2012-2017
  2.3.4 Inosine pranobex
  2.3.5 Melotonin
  2.3.6 Killer helper factor,KHF
  2.3.7 Thymopentin
  2.3.8 Interleukin
γ-globulin
Interferon
Ubenimex
Pidotimod
Thymopentin

CHAPTER THREE IMMUNE SYSTEM DRUGS BY REGIONS 2012-2017

3.1 Global Immune system drugs Sales Market Share by Regions 2012-2017
3.2 Global Immune system drugs Revenue Market Share by Regions 2012-2017
3.3 Global Immune system drugs Price by Regions 2012-2017
3.4 North America
  3.4.1 United States
    3.4.1.1 California
    3.4.1.2 Texas
    3.4.1.3 New York
    3.4.1.4 Others in United States
  3.4.2 Canada
3.5 Latin America
  3.5.1 Mexico
  3.5.2 Brazil
  3.5.3 Argentina
  3.5.4 Others in Latin America
3.6 Europe
  3.6.1 Germany
  3.6.2 United Kingdom
  3.6.3 France
  3.6.4 Italy
  3.6.5 Spain
  3.6.6 Russia
  3.6.7 Netherland
  3.6.8 Others in Europe
3.7 Asia & Pacific
  3.7.1 China
  3.7.2 Japan
  3.7.3 India
  3.7.4 Korea
  3.7.5 Australia
  3.7.6 Southeast Asia
    3.7.6.1 Indonesia
    3.7.6.2 Thailand
    3.7.6.3 Philippines
    3.7.6.4 Vietnam
    3.7.6.5 Singapore
    3.7.6.6 Malaysia
    3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
  3.8.1 South Africa
  3.8.2 Egypt
  3.8.3 Turkey
  3.8.4 Saudi Arabia
  3.8.5 Iran
  3.8.6 Others in Africa & Middle East

CHAPTER FOUR GLOBAL IMMUNE SYSTEM DRUGS BY COMPANIES 2012-2017

4.1 Global Immune system drugs Sales Volume Market Share by Companies 2012-2017
4.2 Global Immune system drugs Revenue Share by Companies 2012-2017
4.3 Global Top Companies Immune system drugs Key Product Model and Market Performance
4.4 Global Top Companies Immune system drugs Key Target Consumers and Market Performance

CHAPTER FIVE UNITED STATES IMMUNE SYSTEM DRUGS BY COMPANIES 2012-2017

5.1 United States Immune system drugs Sales Volume Market Share by Companies 2012-2017
5.2 United States Immune system drugs Revenue Share by Companies 2012-2017
5.3 United States Top Companies Immune system drugs Key Product Model and Market Performance
5.4 United States Top Companies Immune system drugs Key Target Consumers and Market Performance

CHAPTER SIX GLOBAL IMMUNE SYSTEM DRUGS BY CONSUMER 2012-2017

6.1 Global Immune system drugs Sales Market Share by Consumer 2012-2017
6.2 Internal Medicine
6.3 Department of surgery
6.4 Infections Department
6.5 Hospital
6.6 Consuming Habit and Preference

CHAPTER SEVEN GLOBAL IMMUNE SYSTEM DRUGS BY CONSUMER 2012-2017

7.1 Global Immune system drugs Sales Market Share by Consumer 2012-2017
7.2 Internal Medicine
7.3 Department of surgery
7.4 Infections Department
7.5 Hospital
7.6 Consuming Habit and Preference

CHAPTER EIGHT TOP COMPANIES PROFILE

8.1 ABBVIE
  8.1.1 ABBVIE Company Details and Competitors
  8.1.2 ABBVIE Key Immune system drugs Models and Performance
  8.1.3 ABBVIE Immune system drugs Business SWOT Analysis and Forecast
  8.1.4 ABBVIE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.2 ACCORD HLTHCARE
  8.2.1 ACCORD HLTHCARE Company Details and Competitors
  8.2.2 ACCORD HLTHCARE Key Immune system drugs Models and Performance
  8.2.3 ACCORD HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
  8.2.4 ACCORD HLTHCARE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.3 AKORN INC
  8.3.1 AKORN INC Company Details and Competitors
  8.3.2 AKORN INC Key Immune system drugs Models and Performance
  8.3.3 AKORN INC Immune system drugs Business SWOT Analysis and Forecast
  8.3.4 AKORN INC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.4 ALLERGAN
  8.4.1 ALLERGAN Company Details and Competitors
  8.4.2 ALLERGAN Key Immune system drugs Models and Performance
  8.4.3 ALLERGAN Immune system drugs Business SWOT Analysis and Forecast
  8.4.4 ALLERGAN Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.5 AMNEAL PHARMS LLC
  8.5.1 AMNEAL PHARMS LLC Company Details and Competitors
  8.5.2 AMNEAL PHARMS LLC Key Immune system drugs Models and Performance
  8.5.3 AMNEAL PHARMS LLC Immune system drugs Business SWOT Analysis and Forecast
  8.5.4 AMNEAL PHARMS LLC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.6 ANTARES PHARMA INC
  8.6.1 ANTARES PHARMA INC Company Details and Competitors
  8.6.2 ANTARES PHARMA INC Key Immune system drugs Models and Performance
  8.6.3 ANTARES PHARMA INC Immune system drugs Business SWOT Analysis and Forecast
  8.6.4 ANTARES PHARMA INC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.7 APOTEX
  8.7.1 APOTEX Company Details and Competitors
  8.7.2 APOTEX Key Immune system drugs Models and Performance
  8.7.3 APOTEX Immune system drugs Business SWOT Analysis and Forecast
  8.7.4 APOTEX Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.8 ASTELLAS
  8.8.1 ASTELLAS Company Details and Competitors
  8.8.2 ASTELLAS Key Immune system drugs Models and Performance
  8.8.3 ASTELLAS Immune system drugs Business SWOT Analysis and Forecast
  8.8.4 ASTELLAS Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.9 BAXTER HLTHCARE
  8.9.1 BAXTER HLTHCARE Company Details and Competitors
  8.9.2 BAXTER HLTHCARE Key Immune system drugs Models and Performance
  8.9.3 BAXTER HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
  8.9.4 BAXTER HLTHCARE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.10 BAYER HEALTHCARE PHARMS
  8.10.1 BAYER HEALTHCARE PHARMS Company Details and Competitors
  8.10.2 BAYER HEALTHCARE PHARMS Key Immune system drugs Models and Performance
  8.10.3 BAYER HEALTHCARE PHARMS Immune system drugs Business SWOT Analysis and Forecast
  8.10.4 BAYER HEALTHCARE PHARMS Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
8.11 DAVA PHARMS INC
8.12 DR REDDYS LABS LTD
8.13 FRESENIUS KABI USA
8.14 GLENMARK GENERICS
8.15 HOSPIRA
8.16 IVAX SUB TEVA PHARMS
8.17 MAYNE PHARMA
8.18 MYLAN
8.19 NOVARTIS
8.20 ROCHE PALO
8.21 SANDOZ
8.22 SANOFI AVENTIS US
8.23 STRIDES PHARMA
8.24 TEVA PHARMS
8.25 VELOXIS PHARMS INC
8.26 VIDARA THERAPEUTICS RESEARCH LTD
8.27 VINTAGE PHARMS LLC
8.28 WATSON LABS
8.29 WEST-WARD PHARMS INT
8.30 ZYDUS PHARMS USA

CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN

9.1 Immune system drugs Industry Chain Structure
  9.1.1 R&D
  9.1.2 Raw Materials (Components)
  9.1.3 Manufacturing Plants
  9.1.4 Regional Trading (Import Export and Local Sales)
  9.1.5 Online Sales Channel
  9.1.6 Offline Channel
  9.1.7 End Users
9.2 Immune system drugs Manufacturing
  9.2.1 Key Components
  9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment

CHAPTER TEN GLOBAL IMMUNE SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Immune system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Immune system drugs Sales () Forecast by Regions (2017-2022)
10.3 Global Immune system drugs Sales () Forecast by Application (2017-2022)
10.4 Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
10.5 Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)

CHAPTER ELEVEN UNITED STATES IMMUNE SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 United States Immune system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Immune system drugs Sales () Forecast by Regions (2017-2022)
11.3 United States Immune system drugs Sales () Forecast by Application (2017-2022)
11.4 United States Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
11.5 United States Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)

CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION

12.1 Development Trend
12.2 Research Conclusion

CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Table Global Immune system drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
Figure Global Immune system drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Immune system drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Immune system drugs Sales () by Immunosuppressive drugs (2012-2017)
Table Global Immune system drugs Sales Market Share by Immunosuppressive drugs (2012-2017)
Figure Global Immune system drugs Sales Market Share by Immunosuppressive drugs in 2016
Table Global Immune system drugs Revenue (Million USD) by Immunosuppressive drugs (2012-2017)
Table Global Immune system drugs Revenue Market Share by Immunosuppressive drugs (2012-2017)
Figure Global Immune system drugs Revenue Market Share by Immunosuppressive drugs in 2016
Table Global Immune system drugs Price () by Immunosuppressive drugs (2012-2017)
Table Top Companies of Azathioprine Immune system drugs Products List
Figure Global Azathioprine Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Tripterygium Glycosides Immune system drugs Products List
Figure Global Tripterygium Glycosides Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Cyclosporine Immune system drugs Products List
Figure Global Cyclosporine Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Sandimmune Immune system drugs Products List
Figure Global Sandimmune Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Ciclosporin Immune system drugs Products List
Figure Global Ciclosporin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Global Immune system drugs Sales () by Immunoregulants (2012-2017)
Table Global Immune system drugs Sales Market Share by Immunoregulants (2012-2017)
Figure Global Immune system drugs Sales Market Share by Immunoregulants in 2016
Table Global Immune system drugs Revenue (Million USD) by Immunoregulants (2012-2017)
Table Global Immune system drugs Revenue Market Share by Immunoregulants (2012-2017)
Figure Global Immune system drugs Revenue Market Share by Immunoregulants in 2016
Table Global Immune system drugs Price () by Immunoregulants (2012-2017)
Table Top Companies of Inosine pranobex Immune system drugs Products List
Figure Global Inosine pranobex Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Melotonin Immune system drugs Products List
Figure Global Melotonin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Killer helper factor,KHF Immune system drugs Products List
Figure Global Killer helper factor,KHF Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Thymopentin Immune system drugs Products List
Figure Global Thymopentin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Interleukin Immune system drugs Products List
Figure Global Interleukin Immune system drugs Sales () and Growth Rate (2012-2017)
Figure United States Immune system drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Immune system drugs Sales Volume () and Growth Rate (2012-2017)
Table United States Immune system drugs Sales () by Immunosuppressive drugs (2012-2017)
Table United States Immune system drugs Sales Market Share by Immunosuppressive drugs (2012-2017)
Figure United States Immune system drugs Sales Market Share by Immunosuppressive drugs in 2016
Table United States Immune system drugs Revenue (Million USD) by Immunosuppressive drugs (2012-2017)
Table United States Immune system drugs Revenue Market Share by Immunosuppressive drugs (2012-2017)
Figure United States Immune system drugs Revenue Market Share by Immunosuppressive drugs in 2016
Table United States Immune system drugs Price () by Immunosuppressive drugs (2012-2017)
Table Top Companies of Azathioprine Immune system drugs Products List
Figure United States Azathioprine Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Tripterygium Glycosides Immune system drugs Products List
Figure United States Tripterygium Glycosides Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Cyclosporine Immune system drugs Products List
Figure United States Cyclosporine Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Sandimmune Immune system drugs Products List
Figure United States Sandimmune Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Ciclosporin Immune system drugs Products List
Figure United States Ciclosporin Immune system drugs Sales () and Growth Rate (2012-2017)
Table United States Immune system drugs Sales () by Immunoregulants (2012-2017)
Table United States Immune system drugs Sales Market Share by Immunoregulants (2012-2017)
Figure United States Immune system drugs Sales Market Share by Immunoregulants in 2016
Table United States Immune system drugs Revenue (Million USD) by Immunoregulants (2012-2017)
Table United States Immune system drugs Revenue Market Share by Immunoregulants (2012-2017)
Figure United States Immune system drugs Revenue Market Share by Immunoregulants in 2016
Table United States Immune system drugs Price () by Immunoregulants (2012-2017)
Table Top Companies of Inosine pranobex Immune system drugs Products List
Figure United States Inosine pranobex Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Melotonin Immune system drugs Products List
Figure United States Melotonin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Killer helper factor,KHF Immune system drugs Products List
Figure United States Killer helper factor,KHF Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Thymopentin Immune system drugs Products List
Figure United States Thymopentin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Companies of Interleukin Immune system drugs Products List
Figure United States Interleukin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Global Immune system drugs Sales () by Regions (2012-2017)
Table Global Immune system drugs Sales Share by Regions (2012-2017)
Figure Global Immune system drugs Sales Market Share by Regions in 2016
Figure Global Immune system drugs Sales Market Share by Regions in 2017
Table Global Immune system drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Immune system drugs Revenue Market Share by Regions (2012-2017)
Figure Global Immune system drugs Revenue Market Share by Regions in 2016
Figure Global Immune system drugs Revenue Market Share by Regions in 2017
Table Global Immune system drugs Price () by Regions (2012-2017)
Table North America Immune system drugs Sales () by Regions (2012-2017)
Table North America Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Figure North America Immune system drugs Sales () and Growth Rate (2012-2017)
Table United States Immune system drugs Sales () by Regions (2012-2017)
Table United States Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Figure United States Immune system drugs Sales () and Growth Rate (2012-2017)
Table Latin America Immune system drugs Sales () by Regions (2012-2017)
Table Latin America Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Immune system drugs Sales () and Growth Rate (2012-2017)
Table Europe Immune system drugs Sales () by Regions (2012-2017)
Table Europe Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Europe Immune system drugs Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Immune system drugs Sales () by Regions (2012-2017)
Table Asia & Pacific Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Immune system drugs Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Immune system drugs Sales () by Regions (2012-2017)
Table Africa & Middle East Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Immune system drugs Sales () and Growth Rate (2012-2017)
Table Global Immune system drugs Sales Volume () by Major Companies (2012-2017)
Table Global Immune system drugs Sales Volume Market Share by Major Companies (2012-2017)
Figure Global Immune system drugs Sales Volume Market Share by Major Companies 2016
Figure Global Immune system drugs Sales Volume Market Share by Major Companies 2017
Table Global Immune system drugs Revenue (Million USD) by Major Companies (2012-2017)
Table Global Immune system drugs Revenue Market Share by Major Companies (2012-2017)
Figure Global Immune system drugs Revenue Market Share by Major Companies 2016
Figure Global Immune system drugs Revenue Market Share by Major Companies 2017
Table Global Top Companies Key Product Model and Market Performance
Table Global Top Companies Key Target Consumers and Market Performance
Table United States Immune system drugs Sales Volume () by Top Companies (2012-2017)
Table United States Immune system drugs Sales Volume Market Share by Top Companies (2012-2017)
Figure United States Immune system drugs Sales Volume Market Share by Top Companies 2016
Figure United States Immune system drugs Sales Volume Market Share by Top Companies 2017
Table United States Immune system drugs Revenue (Million USD) by Top Companies (2012-2017)
Table United States Immune system drugs Revenue Market Share by Top Companies (2012-2017)
Figure United States Immune system drugs Revenue Market Share by Top Companies 2016
Figure United States Immune system drugs Revenue Market Share by Top Companies 2017
Table United States Top Companies Key Product Model and Market Performance
Table United States Top Companies Key Target Consumers and Market Performance
Table Global Immune system drugs Sales () by Consumer (2012-2017)
Figure Global Immune system drugs Sales Market Share by Consumer (2012-2017)
Figure Global Immune system drugs Sales Market Share by Consumer in 2016
Figure Global Internal Medicine Immune system drugs Sales () and Growth Rate (2012-2017)
Figure Global Department of surgery Immune system drugs Sales () and Growth Rate (2012-2017)
Figure Global Infections Department Immune system drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Immune system drugs Sales () and Growth Rate (2012-2017)
Table United States Immune system drugs Sales () by Consumer (2012-2017)
Figure United States Immune system drugs Sales Market Share by Consumer (2012-2017)
Figure United States Immune system drugs Sales Market Share by Consumer in 2016
Figure United States Internal Medicine Immune system drugs Sales () and Growth Rate (2012-2017)
Figure United States Department of surgery Immune system drugs Sales () and Growth Rate (2012-2017)
Figure United States Infections Department Immune system drugs Sales () and Growth Rate (2012-2017)
Figure United States Hospital Immune system drugs Sales () and Growth Rate (2012-2017)
Table ABBVIE Company Details and Competitors
Table ABBVIE Key Immune system drugs Models and Performance
Table ABBVIE Immune system drugs Business SWOT Analysis and Forecast
Table ABBVIE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ABBVIE Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure ABBVIE Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure ABBVIE Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure ABBVIE Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table ACCORD HLTHCARE Company Details and Competitors
Table ACCORD HLTHCARE Key Immune system drugs Models and Performance
Table ACCORD HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
Table ACCORD HLTHCARE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ACCORD HLTHCARE Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure ACCORD HLTHCARE Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure ACCORD HLTHCARE Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure ACCORD HLTHCARE Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table AKORN INC Company Details and Competitors
Table AKORN INC Key Immune system drugs Models and Performance
Table AKORN INC Immune system drugs Business SWOT Analysis and Forecast
Table AKORN INC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure AKORN INC Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure AKORN INC Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure AKORN INC Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure AKORN INC Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table ALLERGAN Company Details and Competitors
Table ALLERGAN Key Immune system drugs Models and Performance
Table ALLERGAN Immune system drugs Business SWOT Analysis and Forecast
Table ALLERGAN Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ALLERGAN Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure ALLERGAN Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure ALLERGAN Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure ALLERGAN Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table AMNEAL PHARMS LLC Company Details and Competitors
Table AMNEAL PHARMS LLC Key Immune system drugs Models and Performance
Table AMNEAL PHARMS LLC Immune system drugs Business SWOT Analysis and Forecast
Table AMNEAL PHARMS LLC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure AMNEAL PHARMS LLC Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure AMNEAL PHARMS LLC Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure AMNEAL PHARMS LLC Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure AMNEAL PHARMS LLC Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table ANTARES PHARMA INC Company Details and Competitors
Table ANTARES PHARMA INC Key Immune system drugs Models and Performance
Table ANTARES PHARMA INC Immune system drugs Business SWOT Analysis and Forecast
Table ANTARES PHARMA INC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ANTARES PHARMA INC Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure ANTARES PHARMA INC Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure ANTARES PHARMA INC Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure ANTARES PHARMA INC Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table APOTEX Company Details and Competitors
Table APOTEX Key Immune system drugs Models and Performance
Table APOTEX Immune system drugs Business SWOT Analysis and Forecast
Table APOTEX Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure APOTEX Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure APOTEX Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure APOTEX Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure APOTEX Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table ASTELLAS Company Details and Competitors
Table ASTELLAS Key Immune system drugs Models and Performance
Table ASTELLAS Immune system drugs Business SWOT Analysis and Forecast
Table ASTELLAS Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure ASTELLAS Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure ASTELLAS Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure ASTELLAS Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure ASTELLAS Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table BAXTER HLTHCARE Company Details and Competitors
Table BAXTER HLTHCARE Key Immune system drugs Models and Performance
Table BAXTER HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
Table BAXTER HLTHCARE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure BAXTER HLTHCARE Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure BAXTER HLTHCARE Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure BAXTER HLTHCARE Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure BAXTER HLTHCARE Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table BAYER HEALTHCARE PHARMS Company Details and Competitors
Table BAYER HEALTHCARE PHARMS Key Immune system drugs Models and Performance
Table BAYER HEALTHCARE PHARMS Immune system drugs Business SWOT Analysis and Forecast
Table BAYER HEALTHCARE PHARMS Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales Market Share (%) in Global (2012-2017)
Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure BAYER HEALTHCARE PHARMS Immune system drugs Revenue Market Share (%) in Global (2012-2017)
Table DAVA PHARMS INC Company Details and Competitors
Table DR REDDYS LABS LTD Company Details and Competitors
Table FRESENIUS KABI USA Company Details and Competitors
Table GLENMARK GENERICS Company Details and Competitors
Table HOSPIRA Company Details and Competitors
Table IVAX SUB TEVA PHARMS Company Details and Competitors
Table MAYNE PHARMA Company Details and Competitors
Table MYLAN Company Details and Competitors
Table NOVARTIS Company Details and Competitors
Table ROCHE PALO Company Details and Competitors
Table SANDOZ Company Details and Competitors
Table SANOFI AVENTIS US Company Details and Competitors
Table STRIDES PHARMA Company Details and Competitors
Table TEVA PHARMS Company Details and Competitors
Table VELOXIS PHARMS INC Company Details and Competitors
Table VIDARA THERAPEUTICS RESEARCH LTD Company Details and Competitors
Table VINTAGE PHARMS LLC Company Details and Competitors
Table WATSON LABS Company Details and Competitors
Table WEST-WARD PHARMS INT Company Details and Competitors
Table ZYDUS PHARMS USA Company Details and Competitors
Figure Global Immune system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Immune system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Immune system drugs Price () Trend Forecast (2017-2022)
Table Global Immune system drugs Sales () Forecast by Regions (2017-2022)
Table Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Immune system drugs Sales Volume Share Forecast by Regions in 2022
Table Global Immune system drugs Sales () Forecast by Application (2017-2022)
Figure Global Immune system drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Immune system drugs Sales Volume Market Share Forecast by Application in 2022
Table Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
Figure Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
Figure Global Immune system drugs Sales Volume Market Share Forecast by Immunosuppressive drugs in 2022
Table Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
Figure Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
Figure Global Immune system drugs Sales Volume Market Share Forecast by Immunoregulants in 2022
Figure United States Immune system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure United States Immune system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Immune system drugs Price () Trend Forecast (2017-2022)
Table United States Immune system drugs Sales () Forecast by Regions (2017-2022)
Table United States Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Immune system drugs Sales Volume Share Forecast by Regions in 2022
Table United States Immune system drugs Sales () Forecast by Application (2017-2022)
Figure United States Immune system drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States Immune system drugs Sales Volume Market Share Forecast by Application in 2022
Table United States Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
Figure United States Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
Figure United States Immune system drugs Sales Volume Market Share Forecast by Immunosuppressive drugs in 2022
Table United States Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
Figure United States Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
Figure United States Immune system drugs Sales Volume Market Share Forecast by Immunoregulants in 2022